Dopamine, when combined with D1 and D2 receptors through the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB/AKT) signaling pathway and CREB, significantly influences neuronal development, synaptic plasticity, and the prevalence and management of mental illnesses [51–53]. The gene discussed is AKT1; the disease is psychiatric disorder.